Ying Huang Selected Research

Ying Huang Research Topics

Disease

351	Neoplasms (Cancer) 12/2022 - 04/2002
89	Infections 11/2022 - 03/2003
68	Inflammation (Inflammations) 06/2022 - 06/2008
43	Neoplasm Metastasis (Metastasis) 12/2022 - 02/2006
41	Breast Neoplasms (Breast Cancer) 06/2022 - 03/2004
39	Carcinogenesis 01/2022 - 09/2004
37	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2002
35	Lung Neoplasms (Lung Cancer) 06/2022 - 09/2007
32	Rectal Neoplasms (Rectal Cancer) 01/2022 - 10/2011
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2009
27	Nasopharyngeal Carcinoma 01/2022 - 07/2003
24	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 08/2010
23	Carcinoma (Carcinomatosis) 01/2022 - 01/2004
23	Atherosclerosis 01/2021 - 03/2006
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 09/2007
22	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2002
21	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 04/2005
20	Adenocarcinoma 09/2021 - 08/2008
19	COVID-19 07/2022 - 01/2020
19	Stomach Neoplasms (Stomach Cancer) 06/2022 - 11/2007
19	Body Weight (Weight, Body) 03/2022 - 02/2008
19	Hypoxia (Hypoxemia) 01/2022 - 12/2005
18	Type 2 Diabetes Mellitus (MODY) 06/2022 - 06/2008
17	Hypertension (High Blood Pressure) 11/2022 - 12/2010
17	Fibrosis (Cirrhosis) 08/2022 - 01/2012
17	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 04/2011
17	Asthma (Bronchial Asthma) 01/2021 - 04/2006
14	Obesity 11/2022 - 11/2007
13	Melanoma (Melanoma, Malignant) 12/2022 - 02/2003
13	Rheumatoid Arthritis 01/2022 - 01/2013
13	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2009
13	Leukemia 01/2021 - 12/2005
13	Myocardial Infarction 01/2019 - 01/2012
11	Hemorrhage 09/2022 - 03/2001
11	Heart Failure 06/2022 - 08/2015
11	Pain (Aches) 02/2022 - 09/2009
11	Esophageal Squamous Cell Carcinoma 01/2022 - 06/2006
10	Wounds and Injuries (Trauma) 02/2022 - 10/2010
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2012
10	Acute Promyelocytic Leukemia 07/2021 - 05/2002
9	HIV Infections (HIV Infection) 01/2022 - 09/2011
9	Sepsis (Septicemia) 01/2022 - 01/2006
9	Multiple Myeloma 12/2021 - 10/2015
9	Virus Diseases (Viral Diseases) 10/2021 - 05/2008
9	Diarrhea 01/2021 - 07/2009
9	Acquired Immunodeficiency Syndrome (AIDS) 12/2020 - 01/2007
9	Ischemia 10/2020 - 03/2009
8	Stroke (Strokes) 01/2022 - 11/2010

Drug/Important Bio-Agent (IBA)

136	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2004
83	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2006
63	Pharmaceutical PreparationsIBA 07/2022 - 04/2003
37	CytokinesIBA 01/2022 - 12/2005
31	Messenger RNA (mRNA)IBA 12/2021 - 10/2003
30	MicroRNAs (MicroRNA)IBA 06/2022 - 11/2010
30	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2003
28	VaccinesIBA 06/2022 - 07/2010
27	Biological ProductsIBA 01/2022 - 02/2003
19	Therapeutic UsesIBA 11/2022 - 01/2002
19	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 09/2006
19	EnzymesIBA 01/2021 - 08/2004
16	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2009
15	AntioxidantsIBA 06/2022 - 03/2010
15	C-Reactive ProteinIBA 01/2021 - 02/2013
14	Small Interfering RNA (siRNA)IBA 11/2022 - 06/2004
14	Peptides (Polypeptides)IBA 08/2022 - 10/2010
14	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2011
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2004
14	LipidsIBA 01/2022 - 04/2010
14	AntigensIBA 12/2021 - 10/2007
14	AntibodiesIBA 07/2021 - 11/2007
14	CholesterolIBA 01/2018 - 12/2009
13	Interleukin-10 (Interleukin 10)IBA 03/2022 - 08/2011
13	InterleukinsIBA 01/2022 - 01/2009
13	Phosphotransferases (Kinase)IBA 10/2021 - 01/2006
13	LipopolysaccharidesIBA 03/2021 - 01/2013
11	CollagenIBA 02/2022 - 08/2009
10	Carvedilol (Coreg)FDA LinkGeneric 01/2022 - 09/2013
10	CateninsIBA 01/2022 - 11/2014
10	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2005
9	Blood Glucose (Blood Sugar)IBA 06/2022 - 12/2010
9	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 12/2015
9	CarbohydratesIBA 01/2022 - 05/2011
9	Carrier Proteins (Binding Protein)IBA 01/2022 - 12/2002
9	Oxygen (Dioxygen)IBA 05/2021 - 06/2006
9	ErbB Receptors (EGF Receptor)IBA 12/2019 - 09/2007
9	LigandsIBA 01/2019 - 07/2005
8	Indicators and Reagents (Reagents)IBA 10/2022 - 10/2009
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2010

Therapy/Procedure

138	Therapeutics 12/2022 - 04/2003
50	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
37	Radiotherapy 04/2022 - 07/2003
29	Neoadjuvant Therapy 01/2022 - 06/2014
18	Chemoradiotherapy 06/2021 - 04/2005
13	Immunotherapy 02/2022 - 01/2012
13	Aftercare (After-Treatment) 04/2021 - 05/2005
13	Chemoprevention 11/2020 - 05/2002
12	Ligation 01/2022 - 09/2005
9	Lasers (Laser) 02/2022 - 09/2005
9	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018 - 09/2012
9	Stents 07/2015 - 02/2007